Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1870979Generated: October 30, 2026

HCID 9822354, compound → HCID 54053863, compound

https://huagongshe.com/reaction/1870979

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHCID 9822354HCID 9822354—
ReactantHCID 18694133HCID 18694133—
ReactantHCID 18694135HCID 18694135—
ReactantHCID 18694141HCID 18694141—
ReactantHCID 18694145HCID 18694145—
ReactantHCID 18694147HCID 18694147—
ReactantHCID 18694157HCID 18694157—
ReactantHCID 18694159HCID 18694159—
ReactantHCID 18694165HCID 18694165—
ReactantHCID 18694192HCID 18694192—
ReactantHCID 53901931HCID 53901931—
ReactantHCID 54513743HCID 54513743—
ReactantHCID 86753236HCID 86753236—
ProductHCID 54053863HCID 54053863—

Reaction Steps

N-[(2,3,4,7,8,9-hexahydrocyclopenta[h]-1-benzopyran-2-yl)methyl]-N'-2-pyrimidinyl-1,3-propanediamine; (±)-N-[(2,3,4,8,9,10-hexahydrobenzo[2,1-b:3,4-b']dipyran-2-yl)methyl]-N'-2-pyrimidinyl-1,3-propane diamine; N-[(3,4,7,8,9,10-hexahydro-2H-naphtho[1,2-b]pyran-2-yl)methyl]-N'-2-pyrimidinyl-1,3-propanediamine; N-(4,5-dihydro-1H-imidazol-2-yl)-N'-[(2,3,4,7,8,9-hexahydrocyclopenta[h]-1-benzopyran-2-yl)methyl]-1,3-propanediamine; N-[(2,3,4,7,8,9-hexahydrobenzo[2,1-b:3,4-b']dipyran-2-yl)methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; N-[(2,3,4,7,8,9-hexahydrocyclopenta[h]-1-benzopyran-2-yl)methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; N-[(2,3,7,8-tetrahydro-9H-pyrano[2,3-f]-1,4-benzodioxin-9-yl)methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; N-[(3,4,7,8,9,10-hexahydro-2H-naphtho[1,2-b]pyran-2-yl)methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; methyl 3-[6-fluoro-3,4-dihydro-2-[[[3-(2-pyrimidinylamino)propyl]amino]methyl]-2H-1-benzopyran-8-yl]-2-propenoate; N-[[6-fluoro-8-(2-furanyl)-3,4-dihydro-2H-1-benzopyran-2-yl]methyl]-N'-2-pyrimidinyl-1,3-propanediamine; N-[[6-fluoro-3,4-dihydro-8-(2-thienyl)-2H-1-benzopyran-2-yl]methyl]-N'-(1,4,5,6-tetrahydro-2-pyrimidinyl)-1,3-propanediamine; N-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-N'-(3,4,5,6-tetrahydro-2-pyridinyl)-1,3-propanediamine; N4 -[3-[[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]amino]propyl]-N2-methyl-2,4-pyrimidinediamine, the pharmaceutically acceptable acid addition salts thereof and the stereochemically isomeric forms thereof.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06100268
Source datasetuspto-grants-2000_08
ORD IDord-dfa0edb2aff843d9a66ff9903a5c9e72
Source noteuspto-grants-2000_08